Tag Archives: IMMU

Top 10 Low Price Stocks To Invest In 2019

You don’t have to invest in penny stocks to find low priced-stocks that represent good values. There are plenty of companies that trade under $20 that have exceptional growth potential. You might even call the price point the sweet spot of investing.

We asked three Motley Fool contributors to identify top stocks under $20 that investors could buy right now to generate exceptional returns. Below they discuss Crocs (NASDAQ:CROX), Sirius XM Holdings (NASDAQ:SIRI), and Wendy’s (NASDAQ:WEN).

Image source: Getty Images.

Getting back on the right foot

Dan Caplinger (Crocs): Many apparel and footwear companies go through a brief period of popularity, establishing a fashion craze that quickly flames out. Crocs appeared to be exactly that sort of company, with its now-famous sandals with holes having created a huge business that sent the stock soaring in 2007. Yet the financial crisis threw the footwear specialist for a loop, and even after a modest recovery in 2010 and 2011, Crocs struggled to put together a lasting turnaround strategy. By last year, shares had lost 90% of their value from the 2007 peak.

Top 10 Low Price Stocks To Invest In 2019: BlackRock New Jersey Municipal Income Trust(BNJ)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Blackrock New Jersey Municipal Income Tr (NYSE:BNJ) have been trending positive on Wednesday, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Blackrock New Jersey Municipal Income Tr earned a news impact score of 0.32 on Accern’s scale. Accern also gave media coverage about the investment management company an impact score of 47.9578208138909 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Headlines about Blackrock New Jersey Municipal Income Tr (NYSE:BNJ) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Blackrock New Jersey Municipal Income Tr earned a news impact score of 0.36 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 48.5554072096128 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Low Price Stocks To Invest In 2019: Evercore Partners Inc(EVR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    EVRAZ plc (LON:EVR)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 578 ($7.53) and last traded at GBX 578 ($7.53), with a volume of 1513584 shares trading hands. The stock had previously closed at GBX 568.20 ($7.40).

Top 10 Low Price Stocks To Invest In 2019: Fiserv, Inc.(FISV)

Advisors’ Opinion:

  • [By Max Byerly]

    Fiserv Inc (NASDAQ:FISV) – Wedbush boosted their FY2018 earnings per share estimates for shares of Fiserv in a report released on Monday, August 13th. Wedbush analyst M. Katri now anticipates that the business services provider will earn $3.14 per share for the year, up from their previous estimate of $3.12. Wedbush also issued estimates for Fiserv’s Q4 2018 earnings at $0.84 EPS, Q3 2019 earnings at $0.87 EPS, Q4 2019 earnings at $0.91 EPS and FY2019 earnings at $3.47 EPS.

  • [By Shane Hupp]

    Fiserv (NASDAQ:FISV) last released its quarterly earnings data on Thursday, February 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.84. Fiserv had a return on equity of 47.56% and a net margin of 20.39%. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the firm posted $0.71 EPS. The business’s revenue for the quarter was up 2.3% compared to the same quarter last year. Equities analysts expect that Fiserv Inc will post 3.46 EPS for the current fiscal year.

    ILLEGAL ACTIVITY NOTICE: “Checchi Capital Advisers LLC Has $581,000 Position in Fiserv Inc (FISV)” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4163064/checchi-capital-advisers-llc-has-581000-position-in-fiserv-inc-fisv.html.

    Fiserv Profile

  • [By Max Byerly]

    Shares of Fiserv Inc (NASDAQ:FISV) have earned an average rating of “Hold” from the eighteen brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokers that have covered the stock in the last year is $76.82.

  • [By Max Byerly]

    Cerity Partners LLC reduced its stake in Fiserv Inc (NASDAQ:FISV) by 0.5% during the fourth quarter, HoldingsChannel reports. The firm owned 27,751 shares of the business services provider’s stock after selling 139 shares during the quarter. Cerity Partners LLC’s holdings in Fiserv were worth $2,039,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Invest In 2019: Fortinet, Inc.(FTNT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Aldebaran Financial Inc. lessened its holdings in Fortinet Inc (NASDAQ:FTNT) by 5.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 83,572 shares of the software maker’s stock after selling 5,040 shares during the period. Fortinet accounts for approximately 3.6% of Aldebaran Financial Inc.’s portfolio, making the stock its 3rd largest holding. Aldebaran Financial Inc.’s holdings in Fortinet were worth $5,217,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Fortinet (NASDAQ:FTNT) issued an update on its first quarter 2019 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.37-0.39 for the period, compared to the Thomson Reuters consensus estimate of $0.41. The company issued revenue guidance of $465-475 million, compared to the consensus revenue estimate of $470.4 million.Fortinet also updated its FY 2019 guidance to $2.05-2.10 EPS.

  • [By Chris Lange]

    Fortinet Inc.’s (NASDAQ: FTNT) short interest increased to 7.23 million shares from the previous 6.98 million. Shares were trading at $89.51. The 52-week range is $35.44 to $91.27.

  • [By Timothy Green]

    Cybersecurity company Fortinet (NASDAQ:FTNT) announced its first-quarter results after the market closed on May 3. The report featured double-digit revenue expansion and explosive earnings growth, and the company expects its third-generation network security products to drive continued growth for the next few years. Here’s what investors need to know about Fortinet’s first-quarter results.

  • [By Lee Samaha]

    Stock in cybersecurity company Fortinet, Inc. (NASDAQ:FTNT) surged 10.5% in May according to data from S&P Global Market Intelligence. The catalyst for the move appears to be a strong, but somewhat confusing, set of first-quarter results given at the start of the month.

  • [By Chris Lange]

    Fortinet Inc.’s (NASDAQ: FTNT) short interest increased to 4.68 million shares from the previous 3.93 million. Shares were trading at $56.07. The 52-week range is $35.44 to $57.98.

Top 10 Low Price Stocks To Invest In 2019: Fogo de Chao, Inc.(FOGO)

Advisors’ Opinion:

  • [By Max Byerly]

    Fogo De Chao (NASDAQ: FOGO) and Habit Restaurants (NASDAQ:HABT) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

  • [By Dustin Parrett]

    But with a VQScore of 4, our top score, this company is one of the best stocks you can buy right now, which means the Raymond James rating might be too conservative. Not only are you getting a company with growth potential, you’re getting it at an excellent price.

    Restaurant Stocks to Buy, No. 2: Fogo de Chao Inc. (Nasdaq: FOGO)

    Fogo de Chao Inc. (Nasdaq: FOGO) is upscale Brazilian steakhouse, originally opened in Brazil in 1979. Fogo de Chao currently has 47 restaurants across the world.

  • [By Ethan Ryder]

    Fogo De Chao (NASDAQ:FOGO) and Texas Roadhouse (NASDAQ:TXRH) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.

Top 10 Low Price Stocks To Invest In 2019: Advantest Corporation (Kabushiki Kaisha Advantest) ADS(ATE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Antibe Therapeutics Inc (CVE:ATE) Director Nicolas Bourgeois bought 100,000 shares of Antibe Therapeutics stock in a transaction on Tuesday, September 18th. The shares were acquired at an average price of C$0.26 per share, for a total transaction of C$26,000.00.

Top 10 Low Price Stocks To Invest In 2019: Videocon d2h Limited(VDTH)

Advisors’ Opinion:

  • [By Shane Hupp]

    News headlines about Videocon d2h (NASDAQ:VDTH) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Videocon d2h earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the company an impact score of 44.8019957983193 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Logan Wallace]

    Videocon d2h (NASDAQ: VDTH) and MSG Networks (NYSE:MSGN) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Joseph Griffin]

    Videocon d2h (NASDAQ: VDTH) and DISCOVERY COMMUNICATIONS INC. Common Stock (NASDAQ:DISCA) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Top 10 Low Price Stocks To Invest In 2019: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Logan Wallace]

    Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.

  • [By Max Byerly]

    Swiss National Bank cut its holdings in Immunomedics, Inc. (NASDAQ:IMMU) by 4.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 203,050 shares of the biopharmaceutical company’s stock after selling 8,600 shares during the period. Swiss National Bank’s holdings in Immunomedics were worth $4,806,000 at the end of the most recent reporting period.

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

Top 10 Low Price Stocks To Invest In 2019: Broadcom Corporation(BRCM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Broadcom Inc. (NASDAQ: BRCM) traded down about 1.4% Friday and posted a new 52-week low of $222.00 after closing Thursday at $225.25. The stock’s 52-week high is $285.68. Volume totaled around 3.9 million, just under the daily average of about 4.1 million. The company had no specific news.

  • [By Max Byerly]

    Headlines about Broadcom (NASDAQ:BRCM) have trended somewhat positive this week, according to Accern Sentiment. The research firm scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Broadcom earned a news impact score of 0.16 on Accern’s scale. Accern also gave media headlines about the semiconductor manufacturer an impact score of 43.7335359332371 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Low Price Stocks To Invest In 2019: Pan American Silver Corp.(PAAS)

Advisors’ Opinion:

  • [By Neha Chamaria]

    Silver prices hit lows not seen since 2016 last week. Silver stocks, unsurprisingly, are getting beaten up, too. Shares of Pan American Silver (NASDAQ:PAAS), for instance, have dropped 16% in the past three months. Wheaton Precious Metals (NYSE:WPM) has fared even worse, losing a quarter of its value during that period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pan American Silver (PAAS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pan American Silver (PAAS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news stories that may have impacted Accern’s analysis:

    Get Pan American Silver alerts:

    Analyzing McEwen Mining (MUX) & Pan American Silver (PAAS) (americanbankingnews.com) Brokerages Anticipate Pan American Silver Corp. (PAAS) Will Post Quarterly Sales of $216.36 Million (americanbankingnews.com) Pan American Silver Corp. (PAAS) Given Average Recommendation of “Buy” by Brokerages (americanbankingnews.com) Pan American Silver Corp. (PAAS) Expected to Post Earnings of $0.16 Per Share (americanbankingnews.com)

    Several analysts have weighed in on PAAS shares. BidaskClub cut shares of Pan American Silver from a “hold” rating to a “sell” rating in a research note on Wednesday, June 6th. ValuEngine upgraded shares of Pan American Silver from a “sell” rating to a “hold” rating in a research note on Friday, March 23rd. Canaccord Genuity restated a “buy” rating and issued a $19.50 target price on shares of Pan American Silver in a research report on Wednesday, April 4th. Finally, Deutsche Bank dropped their target price on shares of Pan American Silver from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Thursday, March 15th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Pan American Silver has a consensus rating of “Buy” and a consensus target price of $21.10.

Top 10 Medical Stocks To Own For 2019

Investment company Matthews Pacific Tiger Fund buys Wise Talent Information Technology Co, sells Shandong Weigao Group Medical Polymer Co, AmorePacific Corp, PT Astra International Tbk during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Matthews Pacific Tiger Fund. As of 2018-06-30, Matthews Pacific Tiger Fund owns 66 stocks with a total value of $9.1 billion. These are the details of the buys and sells.

New Purchases: 06100, Added Positions: 035420, 600887, 524715, 02611, 030000, YUMC, 532155, 139480, SCMA, 005830, Reduced Positions: 01066, 090430, 00700, 01044, 500114, 00291, CPN, BIDU, 3182, VNM, Sold Out: ASII,

For the details of Matthews Pacific Tiger Fund’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Matthews+Pacific+Tiger+Fund

These are the top 5 holdings of Matthews Pacific Tiger FundChina Resources Beer (Holdings) Co Ltd (00291) – 70,257,775 shares, 3.74% of the total portfolio. Shares reduced by 6.77%Kotak Mahindra Bank Ltd (500247) – 16,123,409 shares, 3.48% of the total portfolio. Ping An Insurance (Group) Co. of China Ltd (02318) – 31,734,000 shares, 3.19% of the total portfolio. Baidu Inc (BIDU) – 1,174,300 shares, 3.13% of the total portfolio. Shares reduced by 3.09%Tencent Holdings Ltd (00700) – 5,336,500 shares, 2.94% of the total portfolio. Shares reduced by 9.34%New Purchase: Wise Talent Information Technology Co Ltd (06100)

Matthews Pacific Tiger Fund initiated holding in Wise Talent Information Technology Co Ltd. The purchase prices were between $32.5 and $32.5, with an estimated average price of $32.5. The stock is now traded at around $28.20. The impact to a portfolio due to this purchase was 0.4%. The holding were 8,838,800 shares as of 2018-06-30.

Top 10 Medical Stocks To Own For 2019: BankFinancial Corporation(BFIN)

Advisors’ Opinion:

  • [By Shane Hupp]

    BankFinancial (NASDAQ:BFIN) and Territorial Bancorp (NASDAQ:TBNK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BankFinancial (BFIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BankFinancial (BFIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2019: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ForeScout Technologies (NASDAQ: FSCT) and Immersion (NASDAQ:IMMR) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

  • [By Ethan Ryder]

    Immersion Co. (NASDAQ:IMMR) major shareholder Senvest Management, Llc sold 177,818 shares of the business’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $15.93, for a total transaction of $2,832,640.74. The sale was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

  • [By Shane Hupp]

    Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.

  • [By Max Byerly]

    Immersion Co. (NASDAQ:IMMR) has been assigned an average rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $13.13.

  • [By Evan Niu, CFA]

    Shares of Immersion (NASDAQ:IMMR) got crushed today, down by 23% as of 11:50 a.m. EDT, after the developer of haptic technologies reported second-quarter earnings. An unexpected decline in revenue caught investors off guard.

Top 10 Medical Stocks To Own For 2019: SeaWorld Entertainment, Inc.(SEAS)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of SeaWorld Entertainment (NYSE:SEAS) have popped today, up by 10% as of 12:20 p.m. EDT, after the company reported first-quarter earnings results. The company enjoyed strong gains in park attendance.

  • [By Daniel B. Kline]

    In this episode of Industry Focus: Consumer Goods, Vincent Shen and Motley Fool contributor Dan Kline take a first pass at understanding what it takes to run a theme park with three of the biggest names in the industry — Six Flags (NYSE:SIX), Cedar Fair (NYSE:FUN), and SeaWorld (NYSE:SEAS).

  • [By Rick Munarriz]

    Investors were ready for SeaWorld Entertainment (NYSE:SEAS) to post its strongest growth in five years on Tuesday morning, and they got a whole lot more. Shares of the marine-life park operator are hitting 11-month highs after the company announced head-turning financial results. 

Top 10 Medical Stocks To Own For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Jennison Associates LLC raised its position in shares of Bloomin’ Brands Inc (NASDAQ:BLMN) by 15.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,634 shares of the restaurant operator’s stock after purchasing an additional 8,083 shares during the quarter. Jennison Associates LLC owned 0.06% of Bloomin’ Brands worth $1,199,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Bloomin’ Brands (NASDAQ:BLMN) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  • [By Max Byerly]

    Wall Street analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to post earnings of $0.08 per share for the current quarter, Zacks reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 33.3%. The firm is expected to report its next earnings results on Friday, November 2nd.

  • [By John Ballard]

    The restaurant industry has had a rough few years. Bloomin’ Brands (NASDAQ:BLMN), owner of Outback Steakhouse, and Brinker International (NYSE:EAT), owner of Chili’s Grill and Bar, were hit particularly hard by traffic trends. Some of this can be attributed to shifts in consumer behavior, as diners more than ever are demanding faster service and quality food preparation. 

  • [By Dan Caplinger]

    Thursday was a volatile day on Wall Street, as major stock indexes lost a lot of ground early in the day but then rebounded to finished mixed. Gains for the Nasdaq Composite came even as Dow Jones Industrial Average fell modestly, and although investors spent much of the session trying to parse through the implications of the latest economic report on retail sales, earnings played a key role in moving many well-known stocks. Marathon Oil (NYSE:MRO), AstraZeneca (NYSE:AZN), and Bloomin’ Brands (NASDAQ:BLMN) were among the top performers. Here’s why they did so well.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Top 10 Medical Stocks To Own For 2019: MV Oil Trust(MVO)

Advisors’ Opinion:

  • [By Max Byerly]

    MV Oil Trust (NYSE: MVO) and Petroleo Brasileiro SA Petrobras (NYSE:PBR.A) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

  • [By Stephan Byrd]

    Jones Energy (NYSE: MVO) and MV Oil Trust (NYSE:MVO) are both small-cap oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Top 10 Medical Stocks To Own For 2019: Acacia Research Corporation(ACTG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Acacia Research alerts:

    Insider Selling: Acacia Research Corp (ACTG) President Sells 46,143 Shares of Stock (americanbankingnews.com) Insider Selling: Acacia Research Corp (ACTG) President Sells 66,115 Shares of Stock (americanbankingnews.com) Insider Buying: Acacia Research Corp (ACTG) Insider Acquires 10,000 Shares of Stock (americanbankingnews.com) It may surprise you: OncoSec Medical Incorporated (NASDAQ:ONCS), Mizuho Financial Group, Inc. (NYSE:MFG … (thestreetpoint.com)

    Shares of NASDAQ ACTG traded down $0.05 during midday trading on Tuesday, hitting $3.45. 1,710 shares of the company traded hands, compared to its average volume of 147,059. Acacia Research has a 12-month low of $3.25 and a 12-month high of $5.50. The stock has a market capitalization of $173.23 million, a P/E ratio of 1.16 and a beta of 0.94.

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Medical Stocks To Own For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    UBS Group AG grew its position in Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 20.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,665 shares of the financial services provider’s stock after purchasing an additional 4,558 shares during the quarter. UBS Group AG’s holdings in Interactive Brokers Group were worth $1,793,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Gamble Jones Investment Counsel increased its stake in shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 1.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,263 shares of the financial services provider’s stock after purchasing an additional 918 shares during the period. Gamble Jones Investment Counsel’s holdings in Interactive Brokers Group were worth $4,139,000 as of its most recent SEC filing.

  • [By Jon C. Ogg]

    Interactive Brokers Group Inc. (NASDAQ: IBKR) has a market cap of almost $26 billion, and its shares were trading basically flat at $62.00, after having been down about 1% in earlier trading indications. The consensus analyst target is $70.50, and the 52-week range is $39.70 to $80.32.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Interactive Brokers Group (IBKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

Top 10 Medical Stocks To Own For 2019: Nuveen Preferred Income Opportunites Fund(JPC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Hollencrest Capital Management decreased its stake in Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) by 30.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,587 shares of the financial services provider’s stock after selling 9,649 shares during the period. Hollencrest Capital Management’s holdings in Nuveen Preferred & Income Oprtnts Fnd were worth $200,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) announced a monthly dividend on Wednesday, August 1st, NASDAQ reports. Shareholders of record on Wednesday, August 15th will be given a dividend of 0.061 per share by the financial services provider on Tuesday, September 4th. This represents a $0.73 annualized dividend and a yield of 7.75%. The ex-dividend date is Tuesday, August 14th.

  • [By Ethan Ryder]

    News headlines about Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) have trended positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nuveen Preferred & Income Oprtnts Fnd earned a media sentiment score of 0.42 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 48.1302177844966 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Medical Stocks To Own For 2019: (RUP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rupee (CURRENCY:RUP) traded down 0.9% against the U.S. dollar during the one day period ending at 14:00 PM ET on October 12th. Rupee has a total market capitalization of $802,724.00 and $4.00 worth of Rupee was traded on exchanges in the last day. During the last seven days, Rupee has traded 0% lower against the U.S. dollar. One Rupee coin can now be purchased for approximately $0.0323 or 0.00000515 BTC on exchanges including CoinExchange and CryptoBridge.

  • [By Max Byerly]

    Rupee (CURRENCY:RUP) traded 10.1% higher against the US dollar during the 24 hour period ending at 16:00 PM ET on September 23rd. Over the last week, Rupee has traded 73.1% higher against the US dollar. One Rupee coin can now be bought for $0.0169 or 0.00000252 BTC on major exchanges including CoinExchange and CryptoBridge. Rupee has a total market capitalization of $415,606.00 and approximately $267.00 worth of Rupee was traded on exchanges in the last day.

  • [By Shane Hupp]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe purchased 25,000 shares of Rupert Resources stock in a transaction that occurred on Wednesday, May 30th. The stock was bought at an average cost of C$1.03 per share, for a total transaction of C$25,750.00.

  • [By Stephan Byrd]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe sold 30,000 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of C$0.95, for a total value of C$28,500.00.

Top 10 Medical Stocks To Own For 2019: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Logan Wallace]

    Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.

  • [By Logan Wallace]

    Immunomedics, Inc. (NASDAQ:IMMU) Director Venbio Select Advisor Llc bought 575,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $13,800,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Immunomedics (IMMU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

Top Medical Stocks To Watch For 2019

&l;p&g;Come October of 2018 and Canada will become one of the few developed countries to legalize recreational marijuana for adult-use. This revolutionary move has not only sent a wave of joy in the people of the country, but has also turned into a massive business opportunity for cannabis manufacturers, who had been restricting their output to only medical use until now. Consequently, pot stocks such as Canopy Growth has seen a surge in its stock price in the last few months, as investors are trying to leverage on the potential upside that the stock can offer. The company also has a partnership whereby &l;a href=&q;https://www.forbes.com/companies/constellation-brands/&q;&g;Constellation Brands&l;/a&g; (NYSE: STZ) has a 9.9% stake in the company.

However, the medical marijuana producer witnessed an initial sharp drop in its price after it released its fourth quarter and fiscal 2018 results. The stock plunged more than 10% to CAD 36.93 per share, as the company failed to meet the consensus expectations on both the revenue as well as earnings front. We figure that this is a market over-reaction to the earnings miss and believe that the stock has a huge upside potential with the opening up of the recreational marijuana market in third quarter of fiscal 2019. We have a &l;a href=&q;http://dashboards.trefis.com/no-login-required/8o4SkdRX&q; target=&q;_blank&q;&g;price estimate of CAD 53 per share for Canopy Growth&l;/a&g;.

Top Medical Stocks To Watch For 2019: Flushing Financial Corporation(FFIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Flushing Financial Co. (NASDAQ:FFIC) declared a quarterly dividend on Wednesday, May 30th, RTT News reports. Stockholders of record on Monday, June 11th will be paid a dividend of 0.20 per share by the bank on Friday, June 29th. This represents a $0.80 annualized dividend and a dividend yield of 2.96%.

Top Medical Stocks To Watch For 2019: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Medpace (NASDAQ: MEDP) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, dividends and analyst recommendations.

  • [By Joseph Griffin]

    News stories about Anavex Life Sciences (NASDAQ:AVXL) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Anavex Life Sciences earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned news headlines about the biotechnology company an impact score of 46.1730416635586 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get Anavex Life Sciences alerts:

    Comparing Anavex Life Sciences (AVXL) & Viralytics (VRACY) (americanbankingnews.com) Hot Move to Watch Anavex Life Sciences Corp. (AVXL) (nasdaqplace.com) Anavex Life Sciences (AVXL) and Intrexon (XON) Head to Head Review (americanbankingnews.com) -$0.10 EPS Expected for Anavex Life Sciences (AVXL) This Quarter (americanbankingnews.com)

    A number of equities analysts recently issued reports on the stock. Maxim Group reaffirmed a “buy” rating and set a $7.00 target price (up previously from $5.00) on shares of Anavex Life Sciences in a research report on Thursday, May 31st. Zacks Investment Research lowered shares of Anavex Life Sciences from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Noble Financial set a $7.00 target price on shares of Anavex Life Sciences and gave the stock a “buy” rating in a research report on Wednesday, May 16th. HC Wainwright assumed coverage on shares of Anavex Life Sciences in a research report on Wednesday, May 30th. They set a “buy” rating and a $10.00 target price on the stock. Finally, Roth Capital initiated coverage on shares of Anavex Life Sciences in a research report on Thursday, March 8th. They set a “buy” rating and a $6.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Anavex Life Sciences presently has an average rating of “Buy” and an average target price of $6.55.

Top Medical Stocks To Watch For 2019: Voya International High Dividend Equity Income Fund(IID)

Advisors’ Opinion:

  • [By Logan Wallace]

    ING International High (NYSE:IID) announced a monthly dividend on Wednesday, May 16th, Wall Street Journal reports. Shareholders of record on Monday, June 4th will be given a dividend of 0.052 per share on Friday, June 15th. This represents a $0.62 dividend on an annualized basis and a yield of 9.12%. The ex-dividend date of this dividend is Friday, June 1st.

Top Medical Stocks To Watch For 2019: Safety Insurance Group Inc.(SAFT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub cut shares of Safety Insurance Group (NASDAQ:SAFT) from a strong-buy rating to a buy rating in a research report released on Friday.

    Several other research analysts also recently weighed in on the stock. Compass Point raised shares of Safety Insurance Group from a sell rating to a neutral rating and set a $70.00 target price for the company in a research note on Thursday, March 8th. ValuEngine raised shares of Safety Insurance Group from a hold rating to a buy rating in a research note on Saturday, June 2nd.

  • [By Jordan Wathen]

    Safety Insurance Group (NASDAQ:SAFT) reported that winter weather activity and an accounting change were drags on its first-quarter results, though a lower tax rate was a net positive to the Massachusetts-based insurance company.

  • [By Max Byerly]

    Safety Insurance Group, Inc. (NASDAQ:SAFT) Director Frederic H. Lindeberg sold 2,000 shares of the business’s stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $88.36, for a total value of $176,720.00. Following the completion of the sale, the director now directly owns 16,000 shares of the company’s stock, valued at $1,413,760. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Top Medical Stocks To Watch For 2019: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

  • [By Ethan Ryder]

    Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

  • [By Logan Wallace]

    Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.

Best High Tech Stocks To Own For 2019

German stocks led a selloff Friday in European markets, with major bourses under pressure as trade tensions between the U.S. and other countries look set to be on full display when leaders of the Group of Seven advanced economies gather in Quebec.

From the corporate front, shares of Deutsche Bank AG and Commerzbank AG fell following a report that the German lenders are in discussions about merging.

Best High Tech Stocks To Own For 2019: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Logan Wallace]

    Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

  • [By Ethan Ryder]

    Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Immunomedics, Inc. (NASDAQ:IMMU) Director Venbio Select Advisor Llc bought 575,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $13,800,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Best High Tech Stocks To Own For 2019: Sandy Spring Bancorp, Inc.(SASR)

Advisors’ Opinion:

  • [By Shane Hupp]

    News articles about Sandy Spring Bancorp (NASDAQ:SASR) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sandy Spring Bancorp earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave news headlines about the bank an impact score of 44.8977197847726 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Max Byerly]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Joseph S. Bracewell sold 32,173 shares of the stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $43.36, for a total transaction of $1,395,021.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

  • [By Logan Wallace]

    Maltese Capital Management LLC raised its position in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 230.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 330,712 shares of the bank’s stock after acquiring an additional 230,611 shares during the quarter. Maltese Capital Management LLC owned approximately 0.93% of Sandy Spring Bancorp worth $12,818,000 as of its most recent SEC filing.

  • [By Max Byerly]

    MetLife Investment Advisors LLC lifted its holdings in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 38.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,587 shares of the bank’s stock after buying an additional 4,054 shares during the period. MetLife Investment Advisors LLC’s holdings in Sandy Spring Bancorp were worth $565,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Mark C. Michael sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 18th. The stock was sold at an average price of $41.30, for a total value of $41,300.00. Following the transaction, the director now directly owns 81,590 shares of the company’s stock, valued at $3,369,667. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

  • [By Joseph Griffin]

    LSV Asset Management cut its stake in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 3.4% in the 1st quarter, Holdings Channel reports. The fund owned 92,100 shares of the bank’s stock after selling 3,200 shares during the quarter. LSV Asset Management’s holdings in Sandy Spring Bancorp were worth $3,569,000 as of its most recent filing with the Securities & Exchange Commission.

Best High Tech Stocks To Own For 2019: Caesars Entertainment Corporation(CZR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Caesars Entertainment Co. Common Stock (CZR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Travis Hoium]

    Earnings season begins this week, withWynn Resorts, Limited (NASDAQ:WYNN) reporting on Tuesday, April 24, Las Vegas Sands Corp. (NYSE:LVS)on Wednesday, and MGM Resorts International (NYSE:MGM)on Thursday. Caesars Entertainment (NASDAQ:CZR) will report on May 2 with Melco Resorts (NASDAQ:MLCO) to follow later in May.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caesars Entertainment Co. Common Stock (CZR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best High Tech Stocks To Own For 2019: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get RXi Pharmaceuticals alerts:

    New Research Study on Connective Tissue Growth Factor Market 2018 to 2025 (morningoutlook.com) Hypoxia Inducible Factor 1 Alpha Market Pipeline Therapeutics H1, 2018 Product Description, Mechanism of Action … (exclusiveherald.com) Human Papillomavirus Associated Diseases Market Pipeline Therapeutics 2018 Drug Description, Target Finding, and … (thefreenewsman.com) Warts Market Therapeutic Pipeline H1, Drugs, Diagnostics, Vaccines and Preventive Technologies (newspublicist.com) Brokerages Anticipate RXi Pharmaceuticals Corp (RXII) to Post -$0.56 Earnings Per Share (americanbankingnews.com)

    Shares of RXi Pharmaceuticals traded down $0.01, hitting $2.24, on Tuesday, MarketBeat Ratings reports. 55,400 shares of the stock were exchanged, compared to its average volume of 275,015. The company has a market capitalization of $9.96 million, a price-to-earnings ratio of -0.53 and a beta of 1.15. RXi Pharmaceuticals has a one year low of $1.90 and a one year high of $7.70.

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get RXi Pharmaceuticals alerts:

    Intercellular Adhesion Molecule 1 Market Pipeline Review H1 Products in Clinical Stage, Methodology, therapeutic … (talkinvestor.com) Hypoxia Inducible Factor 1 Alpha Market Research Report H1: Drug Profile, Top Industry Intelligence and Therapeutic … (thestockanalysis.com) Connective Tissue Growth Factor Market Opportunities, Demands, Size, Share, Trends, Industry Sales Area and Its … (trueindustrynews.com) Global Connective Tissue Growth Factor Market 2018 Manufacturing Analysis and Development Forecast 2025 (trueindustrynews.com) Zacks: Analysts Expect RXi Pharmaceuticals Corp (RXII) to Announce -$0.56 EPS (americanbankingnews.com)

    Shares of RXi Pharmaceuticals stock traded down $0.04 on Tuesday, hitting $1.92. The company had a trading volume of 27,600 shares, compared to its average volume of 258,173. The stock has a market capitalization of $8.21 million, a PE ratio of -0.46 and a beta of 1.20. RXi Pharmaceuticals has a 52 week low of $1.90 and a 52 week high of $7.70.

Best High Tech Stocks To Own For 2019: Cadence Design Systems, Inc.(CDNS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Southwest Airlines Inc. (NYSE: LUV) canceled flights across the country in order to inspect the engines of 40 different airplanes. The inspections come a week after a mid-air engine explosion caused the first U.S. air fatality since 2009. Money Morning Executive Editor Bill Patalon breaks down the aftermath of the accident, and explains what it means for both Southwest and Boeing Co. (NYSE: BA).
    The price of Bitcoin pushed back toward $9,000 as the post-tax season breakout continues for the cryptocurrency markets. The total value of the global cryptocurrency market topped $400 billion this morning, a significant recovery from the massive downturn that occurred in the first quarter. As we explained on Saturday, now may be the best time to buy Bitcoin since July 2013. That month was when Money MorningDefense and Tech Specialist Michael A. Robinson went on live television with a bold prediction forBitcoin (BTC), which would be followed by 25,351% gains at the peak of the cryptocurrency’s run. Find out where Bitcoin is heading next, right here.
    Three Stocks to Watch Today: GOOGL, LUV, HAS
    Alphabet Inc. (Nasdaq: GOOGL) leads another busy day of earnings reports on Monday. Wall Street anticipates that the online media giant will report earnings per share (EPS) of $9.21 on top of $24.29 billion in revenue.
    Hasbro Inc. (NYSE: HAS) slumped more than 7.6% in pre-market hours after the company reported earnings. The toymaker reported adjusted EPS of $0.10, well short of the $0.33 expected on Wall Street. The firm also reported weaker-than-expected revenue for the quarter. The firm named Toys ‘R Us as a central reason for poor showing – the company recently liquidated its stores, impacting Hasbro Inc.’s (Nasdaq: HAS) bottom lines.
    Look for earnings reports from Halliburton Co.(NYSE: HAL), Alaska Air Group Inc.(NYSE: ALK), Whirlpool Corp. (NYSE: WHR), TD Ameritrade Holding Corp. (Nasdaq: AMTD), Kimberley-Clark Corp. (NYSE: KMB), Cadence Design Syst

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Shane Hupp]

    Swiss National Bank cut its holdings in Cadence Design Systems (NASDAQ:CDNS) by 12.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 905,900 shares of the software maker’s stock after selling 125,700 shares during the period. Swiss National Bank owned 0.32% of Cadence Design Systems worth $33,310,000 as of its most recent SEC filing.

  • [By Timothy Green]

    Shares of Cadence Design Systems (NASDAQ:CDNS) jumped on Tuesday after the provider of design solutions for integrated circuits and electronic devices reported its first-quarter results. The company beat analyst estimates for both revenue and earnings, and it provided guidance that came in above analyst expectations. As of 1 p.m. EDT, the stock was up about 9.5%.

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D
  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7

Best High Tech Stocks To Own For 2019: REX American Resources Corporation(REX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    REX American Resources (NYSE:REX) will be issuing its quarterly earnings data before the market opens on Wednesday, May 23rd.

    REX American Resources (NYSE:REX) last released its earnings results on Thursday, March 22nd. The energy company reported $0.71 EPS for the quarter. The business had revenue of $109.54 million for the quarter. REX American Resources had a return on equity of 6.18% and a net margin of 8.77%.

  • [By Stephan Byrd]

    LyondellBasell Industries (NYSE: LYB) and REX American Resources (NYSE:REX) are both basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, earnings, analyst recommendations and dividends.

  • [By Max Byerly]

    News stories about REX American Resources (NYSE:REX) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. REX American Resources earned a daily sentiment score of 0.08 on Accern’s scale. Accern also assigned news stories about the energy company an impact score of 47.4779524917954 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Ethan Ryder]

    Green Plains Partners (NASDAQ: GPP) and REX American Resources (NYSE:REX) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Best Blue Chip Stocks To Own Right Now

President Trump needs a new director for his National Economic Council after Gary Cohn resigned.

There’s one candidate in the mix that may really please investors: Chris Liddell, who has served as chief financial officer for two blue chip American companies, GM (GM) and Microsoft (MSFT)

Liddell, like the former Goldman Sachs (GS) executive Cohn, has a background in crunching numbers and dealing with Wall Street.

The New York Times first reported on Saturday that Liddell was the “top contender” to replace Cohn. A senior White House official later confirmed to CNN that Liddell is a “possibility” as a replacement for Cohn. Liddell currently serves in the White House as the director of strategic initiatives, working closely with Jared Kushner.

Ivan Feinseth, director of research and chief investment officer at Tigress Financial Partners, said he did not think an ethics complaint filed against Liddell last year because of meetings he held at the White House with executives of companies that he owned stocks in would be a major issue either.

Best Blue Chip Stocks To Own Right Now: Trimble Navigation Limited(TRMB)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

Best Blue Chip Stocks To Own Right Now: Atlas Energy, L.P.(ATLS)

Advisors’ Opinion:

  • [By Max Byerly]

    Atlas Energy Group (OTCMKTS: ATLS) and Transglobe Energy (NASDAQ:TGA) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Best Blue Chip Stocks To Own Right Now: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.